MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 526888 | Name: AQ-13 dihydrochloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AQ-13 is an aminoquinoline agent potentially for treatment of malaria. AQ-13 is effective against chloroquine-resistant strains of Plasmodium falciparum. It is structurally similar to the widely used chloroquine diphosphate (CQ). Malaria is a major health problem in endemic countries and chemotherapy remains the most important tool in combating it.

Chemical Structure

AQ-13 dihydrochloride
CAS#169815-40-1 (HCl)

Theoretical Analysis

MedKoo Cat#: 526888

Name: AQ-13 dihydrochloride

CAS#: 169815-40-1 (HCl)

Chemical Formula: C16H24Cl3N3

Exact Mass: 0.0000

Molecular Weight: 364.74

Elemental Analysis: C, 52.69; H, 6.63; Cl, 29.16; N, 11.52

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
169815-40-1 (HCl) 32571-49-6 (free base)
Synonym
AQ-13 dihydrochloride; AQ13; AQ 13.
IUPAC/Chemical Name
N1-(7-chloroquinolin-4-yl)-N3,N3-diethylpropane-1,3-diamine dihydrochloride
InChi Key
ZNHBPWZRWNFJPN-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H22ClN3.2ClH/c1-3-20(4-2)11-5-9-18-15-8-10-19-16-12-13(17)6-7-14(15)16;;/h6-8,10,12H,3-5,9,11H2,1-2H3,(H,18,19);2*1H
SMILES Code
CCN(CC)CCCNC1=CC=NC2=CC(Cl)=CC=C12.[H]Cl.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Related CAS# CAS#32571-49-6 (AQ-13 free base) CAS#169815-40-1 (AQ 13 dihydrochloride)

Preparing Stock Solutions

The following data is based on the product molecular weight 364.74 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Mischlinger J, Agnandji ST, Ramharter M. Single dose treatment of malaria - current status and perspectives. Expert Rev Anti Infect Ther. 2016 Jul;14(7):669-78. doi: 10.1080/14787210.2016.1192462. Epub 2016 Jun 7. PubMed PMID: 27254098. 2: Thompson JI, Peck CE, Karvelas G, Hartwell CA, Guarnaccia C, Brown A, Crewther DP. Temporal processing as a source of altered visual perception in high autistic tendency. Neuropsychologia. 2015 Mar;69:148-53. doi: 10.1016/j.neuropsychologia.2015.01.046. Epub 2015 Jan 30. PubMed PMID: 25645512. 3: Held J, Jeyaraj S, Kreidenweiss A. Antimalarial compounds in Phase II clinical development. Expert Opin Investig Drugs. 2015 Mar;24(3):363-82. doi: 10.1517/13543784.2015.1000483. Epub 2015 Jan 7. Review. PubMed PMID: 25563531. 4: Ringsted FM, Massawe IS, Lemnge MM, Bygbjerg IC. Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT). Malar J. 2011 Aug 15;10:238. doi: 10.1186/1475-2875-10-238. PubMed PMID: 21843328; PubMed Central PMCID: PMC3167767. 5: Nishishiro M, Kurihara T, Wakabayashi H, Sakagami H. Effect of tropolone, azulene and azulenequinone derivatives on prostaglandin E2 production by activated macrophage-like cells. Anticancer Res. 2009 Jan;29(1):379-83. PubMed PMID: 19331176. 6: Owusu-Agyei S, Asante KP, Owusu R, Adjuik M, Amenga-Etego S, Dosoo DK, Gyapong J, Greenwood B, Chandramohan D. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. PLoS One. 2008 Jun 25;3(6):e2530. doi: 10.1371/journal.pone.0002530. PubMed PMID: 18575626; PubMed Central PMCID: PMC2430614. 7: Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007 Dec;29(10):697-735. PubMed PMID: 18200333. 8: Mzayek F, Deng H, Mather FJ, Wasilevich EC, Liu H, Hadi CM, Chansolme DH, Murphy HA, Melek BH, Tenaglia AN, Mushatt DM, Dreisbach AW, Lertora JJ, Krogstad DJ. Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers. PLoS Clin Trials. 2007 Jan 5;2(1):e6. PubMed PMID: 17213921; PubMed Central PMCID: PMC1764434. 9: Deng H, Liu H, Krogstad FM, Krogstad DJ. Sensitive fluorescence HPLC assay for AQ-13, a candidate aminoquinoline antimalarial, that also detects chloroquine and N-dealkylated metabolites. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Apr 3;833(2):122-8. Epub 2006 Jan 18. PubMed PMID: 16520100. 10: Ramanathan-Girish S, Catz P, Creek MR, Wu B, Thomas D, Krogstad DJ, De D, Mirsalis JC, Green CE. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques. Int J Toxicol. 2004 May-Jun;23(3):179-89. PubMed PMID: 15204721. 11: Riccio ES, Lee PS, Winegar RA, Krogstad DJ, De D, Mirsalis JC. Genetic toxicology testing of the antimalarial drugs chloroquine and a new analog, AQ-13. Environ Mol Mutagen. 2001;38(1):69-79. PubMed PMID: 11473390.